Mind-body program tested for chronic migraine headaches in adults
Tests a mind-body approach in adults with chronic migraine, checking whether the protocol is feasible.
Plain-language title generated from the registry record
Registry title: Mind Body Intervention for Chronic Migraine Headaches
Key facts
- Where
- Boston, United StatesSee the site
Where in United States
- Beth Israel Deaconess Medical CenterBoston, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Beth Israel Deaconess Medical Center
- Trial code
- NCT06690060
- Record updated
- 17 March 2026
- Original description
The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.Read full original descriptionShow less
Mind Body Intervention for Chronic Migraine Headaches
The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.
Inclusion: Adult (≥ 18 years of age); Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91; A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92; Presence of migraine headaches at least 5 days per month; Willing to engage in a Mind-Body intervention; Willing/able to participate in remote sessions.
Exclusion: Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease); Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain); Diagnosis of cognitive impairment or dementia; Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation; Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered exclusions.